<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500069</url>
  </required_header>
  <id_info>
    <org_study_id>METC-14-3-006</org_study_id>
    <nct_id>NCT02500069</nct_id>
  </id_info>
  <brief_title>Location Specific Differences in Intestinal Brake Activation</brief_title>
  <official_title>The Effect of Intestinal Brake Activation at Different Locations in the Gut on Food Intake and Hormone Release</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The appearance of intact macronutrients in the small intestine can result in the activation&#xD;
      of an intestinal brake; a negative feedback mechanism from different parts of the intestine&#xD;
      to the stomach, the small intestine and to the central nervous system. These processes&#xD;
      inhibit food processing, appetite sensations and food intake, and furthermore they increase&#xD;
      feelings of satiety and satiation. The researchers will investigate the effects of&#xD;
      intraduodenal, intrajejunal and intralileal infusion of casein (protein) on ad libitum food&#xD;
      intake, satiation and in vivo release of the gut satiety peptides CCK, PYY and GLP-1 and&#xD;
      glucose and insulin.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To measure ad libitum food intake at the end of the test day</measure>
    <time_frame>1 test day</time_frame>
    <description>Food intake measurement in kcal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS scores for hunger and satiety</measure>
    <time_frame>1 test day</time_frame>
    <description>Visual analogue scale for hunger and satiety in mm (0-100 mm scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GI peptides</measure>
    <time_frame>1 test day</time_frame>
    <description>Measurement of GI peptide release during protein infusion (CCK, GLP-1, PYY, insulin and glucose)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Ileal Brake</condition>
  <condition>Satiety</condition>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <condition>Overeating</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tap water infusion in all three locations (duodenum, jejunum and ileum)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Duodenum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of casein in duodenum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jejunum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of casein in jejunum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ileum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of casein in ileum</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>infusion of tap water in all regions (duodenum, jejunum and ileum)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Casein (in duodenum)</intervention_name>
    <description>infusion of protein in duodenum</description>
    <arm_group_label>Duodenum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Casein (in jejunum)</intervention_name>
    <description>infusion of protein in jejunum</description>
    <arm_group_label>Jejunum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Casein (in ileum)</intervention_name>
    <description>infusion of protein in ileum</description>
    <arm_group_label>Ileum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
        In order to be eligible to participate in this study, a subject must meet all of the&#xD;
        following criteria:&#xD;
&#xD;
          -  Based on medical history and previous examination, no gastrointestinal complaints can&#xD;
             be defined.&#xD;
&#xD;
          -  Age between 18 and 65 years. This study will include healthy adult subjects (male and&#xD;
             female). Women must be taking contraceptives.&#xD;
&#xD;
          -  BMI between 18 and 25 kg/m2)&#xD;
&#xD;
          -  Weight stable over at least the last 6 months (â‰¤5% weight change)&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
        A potential subject who meets any of the following criteria will be excluded from&#xD;
        participation in this study:&#xD;
&#xD;
          -  History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic,&#xD;
             hematological/immunologic, HEENT (head, ears, eyes, nose, throat),&#xD;
             dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine,&#xD;
             neurological/psychiatric diseases, allergy, major surgery and/or laboratory&#xD;
             assessments which might limit participation in or completion of the study protocol.&#xD;
             The severity of the disease (major interference with the execution of the experiment&#xD;
             or potential influence on the study outcomes) will be decided by the principal&#xD;
             investigator.&#xD;
&#xD;
          -  Use of medication, including vitamin supplementation, except oral contraceptives,&#xD;
             within 14 days prior to testing&#xD;
&#xD;
          -  Administration of investigational drugs or participation in any scientific&#xD;
             intervention study which may interfere with this study (to be decided by the principle&#xD;
             investigator), in the 180 days prior to the study&#xD;
&#xD;
          -  Major abdominal surgery interfering with gastrointestinal function (uncomplicated&#xD;
             appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon&#xD;
             judgement of the principle investigator)&#xD;
&#xD;
          -  Dieting (medically prescribed, vegetarian, diabetic, macrobiological, biological&#xD;
             dynamic)&#xD;
&#xD;
          -  Pregnancy, lactation&#xD;
&#xD;
          -  Excessive alcohol consumption (&gt;20 alcoholic consumptions per week)&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Blood donation within 3 months before the study period&#xD;
&#xD;
          -  Self-admitted HIV-positive state&#xD;
&#xD;
          -  Weight &lt;60kg&#xD;
&#xD;
          -  Evidence of casein or sucrose hypersensitivity&#xD;
&#xD;
          -  Participation in any other study in which radiation was used, within 12 months before&#xD;
             the study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A Masclee, Prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6003</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>March 18, 2014</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <last_update_submitted>July 14, 2015</last_update_submitted>
  <last_update_submitted_qc>July 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Hyperphagia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

